Evidence map›Paper›PMID 32426498›Full record

ArticleScience advances2020

Pathological processes in aqueous humor due to iris atrophy predispose to early corneal graft failure in humans and mice.

Takefumi Yamaguchi, Kazunari Higa, Yukari Yagi-Yaguchi, Koji Ueda, Hisashi Noma, Shinsuke Shibata, Toshihiro Nagai, Daisuke Tomida, Ririko Yasu-Mimura, Osama Ibrahim and 6 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 2 countries.

Takefumi YamaguchiDepartment of Ophthalmology, Tokyo Dental College Ichikawa General Hospital, 5-11-13 Sugano, Ichikawa-shi, Chiba 272-8513, Japan.ORCID 0000-0002-2546-2813
Kazunari HigaDepartment of Ophthalmology, Tokyo Dental College Ichikawa General Hospital, 5-11-13 Sugano, Ichikawa-shi, Chiba 272-8513, Japan.ORCID 0000-0002-2015-3480
Yukari Yagi-YaguchiDepartment of Ophthalmology, Tokyo Dental College Ichikawa General Hospital, 5-11-13 Sugano, Ichikawa-shi, Chiba 272-8513, Japan.ORCID 0000-0002-7980-7741
Koji UedaProject for Realization of Personalized Cancer Medicine, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo 135-8550, Japan.ORCID 0000-0001-9066-4959
Hisashi NomaDepartment of Data Science, The Institute of Statistical Mathematics, 10-3, Midori-cho, Tachikawa, Tokyo 190-0014, Japan.ORCID 0000-0002-2520-9949
Shinsuke ShibataElectron Microscope Laboratory, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan.ORCID 0000-0002-1185-9043
Toshihiro NagaiElectron Microscope Laboratory, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan.
Daisuke TomidaDepartment of Ophthalmology, Tokyo Dental College Ichikawa General Hospital, 5-11-13 Sugano, Ichikawa-shi, Chiba 272-8513, Japan.
Ririko Yasu-MimuraDepartment of Ophthalmology, Tokyo Dental College Ichikawa General Hospital, 5-11-13 Sugano, Ichikawa-shi, Chiba 272-8513, Japan.
Osama IbrahimDepartment of Ophthalmology, Tokyo Dental College Ichikawa General Hospital, 5-11-13 Sugano, Ichikawa-shi, Chiba 272-8513, Japan.
Ryo MatobaDNA Chip Research Inc., Suzue Baydium 5F, 1-15-1, Kaigan, Minato-ku, Tokyo 105-0022, Japan.ORCID 0000-0001-8711-0082
Kazuo TsubotaDepartment of Ophthalmology, Tokyo Dental College Ichikawa General Hospital, 5-11-13 Sugano, Ichikawa-shi, Chiba 272-8513, Japan.ORCID 0000-0002-8874-7111
Pedram HamrahCenter for Translational Ocular Immunology, Tufts Medical Center, Tufts University School of Medicine, Tufts University, 800 Washington St., Boston, MA 02111, USA.
Jun YamadaDepartment of Ophthalmology, Meiji University of Integrative Medicine, Hinotani 6-1, Honoda, Hiyoshi-cho, Nantan-shi, Kyoto 629-0392, Japan.
Kohsuke KanekuraDepartment of Molecular Pathology, Tokyo Medical University, 6-1-1, Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan.ORCID 0000-0002-2901-9595
Jun ShimazakiDepartment of Ophthalmology, Tokyo Dental College Ichikawa General Hospital, 5-11-13 Sugano, Ichikawa-shi, Chiba 272-8513, Japan.ORCID 0000-0002-0435-3095
Tokyo Dental College Ichikawa General Hospital · JPKeio University Hospital · JPDNA Chip Research (Japan) · JPJapanese Foundation For Cancer Research · JPMeiji University of Integrative Medicine · JPThe Institute of Statistical Mathematics · JPTokyo Medical University · JPTufts University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Corneal endothelial cell (CEnC) loss after corneal transplantation is the major cause of graft failure and remains a clinically relevant challenge to overcome. Accumulated knowledge derived from long-term clinical outcomes suggested that elevated protein levels in the aqueous humor are associated with CEnC loss. However, the full spectrum of driver proteins and molecular processes remains to be determined. Here, we defined the somatic microenvironmental landscape and cellular response across human aqueous humor in samples with poor corneal transplantation clinical outcomes using multiomics analyses and clarified specific driver alterations, including complement activation and disturbed energy homeostasis. These driver alterations were also confirmed in aqueous humor from a novel murine model that spontaneously develops iris atrophy, leading to CEnC loss. The application of the integrative multiomics performed in human samples to the novel murine model will help the development of therapeutic modalities for patients with CEnC loss after corneal transplantation.

Indexed as

Corneal DiseasesCorneal TransplantationAnimalsAqueous HumorAtrophyDisease Models, AnimalHumansIrisMice

Identifiers

PMID32426498
PMCPMC7220341
OpenAlexW3025848167

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.